A novel antiangiogenesis therapy using an integrin antagonist or anti–Flk-1 antibody coated 90Y-labeled nanoparticles von Li, Lingyun, Wartchow, Charles A, Danthi, S.Narasimhan, Shen, Zhimin, Dechene, Neal, Pease, John, Choi, H.Steven, Doede, Tina, Chu, Pauline, Ning, Shoucheng, Lee, Daniel Y, Bednarski, Mark D, Knox, Susan J

Volltext